vs

Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and POWER SOLUTIONS INTERNATIONAL, INC. (PSIX). Click either name above to swap in a different company.

ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $191.2M, roughly 1.5× POWER SOLUTIONS INTERNATIONAL, INC.). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 8.4%, a 87.9% gap on every dollar of revenue. On growth, POWER SOLUTIONS INTERNATIONAL, INC. posted the faster year-over-year revenue change (32.5% vs 9.4%). Over the past eight quarters, POWER SOLUTIONS INTERNATIONAL, INC.'s revenue compounded faster (41.7% CAGR vs 17.5%).

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

Adani Energy Solutions Ltd, formerly known as Adani Transmission Ltd, is an electric power transmission and distribution company headquartered in Ahmedabad. As of April 2025, the company operates a cumulative transmission network of 26,696 circuit kilometers and is one of the largest private sector power transmission companies operating in India.

ACAD vs PSIX — Head-to-Head

Bigger by revenue
ACAD
ACAD
1.5× larger
ACAD
$284.0M
$191.2M
PSIX
Growing faster (revenue YoY)
PSIX
PSIX
+23.1% gap
PSIX
32.5%
9.4%
ACAD
Higher net margin
ACAD
ACAD
87.9% more per $
ACAD
96.3%
8.4%
PSIX
Faster 2-yr revenue CAGR
PSIX
PSIX
Annualised
PSIX
41.7%
17.5%
ACAD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACAD
ACAD
PSIX
PSIX
Revenue
$284.0M
$191.2M
Net Profit
$273.6M
$16.1M
Gross Margin
90.8%
21.9%
Operating Margin
6.1%
12.7%
Net Margin
96.3%
8.4%
Revenue YoY
9.4%
32.5%
Net Profit YoY
90.3%
-31.0%
EPS (diluted)
$1.61
$0.69

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACAD
ACAD
PSIX
PSIX
Q4 25
$284.0M
$191.2M
Q3 25
$278.6M
$203.8M
Q2 25
$264.6M
$191.9M
Q1 25
$244.3M
$135.4M
Q4 24
$259.6M
$144.3M
Q3 24
$250.4M
$125.8M
Q2 24
$242.0M
$110.6M
Q1 24
$205.8M
$95.2M
Net Profit
ACAD
ACAD
PSIX
PSIX
Q4 25
$273.6M
$16.1M
Q3 25
$71.8M
$27.6M
Q2 25
$26.7M
$51.2M
Q1 25
$19.0M
$19.1M
Q4 24
$143.7M
$23.3M
Q3 24
$32.8M
$17.3M
Q2 24
$33.4M
$21.5M
Q1 24
$16.6M
$7.1M
Gross Margin
ACAD
ACAD
PSIX
PSIX
Q4 25
90.8%
21.9%
Q3 25
92.2%
23.9%
Q2 25
92.2%
28.2%
Q1 25
91.7%
29.7%
Q4 24
91.6%
29.9%
Q3 24
92.5%
28.9%
Q2 24
92.5%
31.8%
Q1 24
88.8%
27.0%
Operating Margin
ACAD
ACAD
PSIX
PSIX
Q4 25
6.1%
12.7%
Q3 25
12.8%
13.9%
Q2 25
12.2%
16.9%
Q1 25
7.9%
18.2%
Q4 24
59.1%
17.5%
Q3 24
12.6%
16.3%
Q2 24
12.6%
22.9%
Q1 24
7.4%
11.2%
Net Margin
ACAD
ACAD
PSIX
PSIX
Q4 25
96.3%
8.4%
Q3 25
25.8%
13.5%
Q2 25
10.1%
26.7%
Q1 25
7.8%
14.1%
Q4 24
55.4%
16.1%
Q3 24
13.1%
13.8%
Q2 24
13.8%
19.5%
Q1 24
8.0%
7.5%
EPS (diluted)
ACAD
ACAD
PSIX
PSIX
Q4 25
$1.61
$0.69
Q3 25
$0.42
$1.20
Q2 25
$0.16
$2.22
Q1 25
$0.11
$0.83
Q4 24
$0.86
$1.01
Q3 24
$0.20
$0.75
Q2 24
$0.20
$0.94
Q1 24
$0.10
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACAD
ACAD
PSIX
PSIX
Cash + ST InvestmentsLiquidity on hand
$177.7M
$41.3M
Total DebtLower is stronger
$96.6M
Stockholders' EquityBook value
$1.2B
$178.6M
Total Assets
$1.6B
$424.7M
Debt / EquityLower = less leverage
0.54×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACAD
ACAD
PSIX
PSIX
Q4 25
$177.7M
$41.3M
Q3 25
$258.0M
$49.0M
Q2 25
$253.6M
$49.5M
Q1 25
$217.7M
$50.0M
Q4 24
$319.6M
$55.3M
Q3 24
$155.1M
$40.5M
Q2 24
$177.1M
$28.8M
Q1 24
$204.7M
$33.1M
Total Debt
ACAD
ACAD
PSIX
PSIX
Q4 25
$96.6M
Q3 25
$96.7M
Q2 25
$1.8M
Q1 25
$1.0M
Q4 24
$184.0K
Q3 24
$238.0K
Q2 24
$292.0K
Q1 24
$345.0K
Stockholders' Equity
ACAD
ACAD
PSIX
PSIX
Q4 25
$1.2B
$178.6M
Q3 25
$917.3M
$162.5M
Q2 25
$822.4M
$135.7M
Q1 25
$765.2M
$84.3M
Q4 24
$732.8M
$65.3M
Q3 24
$577.2M
$42.1M
Q2 24
$516.7M
$24.8M
Q1 24
$464.0M
$3.2M
Total Assets
ACAD
ACAD
PSIX
PSIX
Q4 25
$1.6B
$424.7M
Q3 25
$1.3B
$458.9M
Q2 25
$1.2B
$437.7M
Q1 25
$1.1B
$372.7M
Q4 24
$1.2B
$328.2M
Q3 24
$976.9M
$339.1M
Q2 24
$914.1M
$307.6M
Q1 24
$855.1M
$286.8M
Debt / Equity
ACAD
ACAD
PSIX
PSIX
Q4 25
0.54×
Q3 25
0.60×
Q2 25
0.01×
Q1 25
0.01×
Q4 24
0.00×
Q3 24
0.01×
Q2 24
0.01×
Q1 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACAD
ACAD
PSIX
PSIX
Operating Cash FlowLast quarter
$-48.7M
$-4.6M
Free Cash FlowOCF − Capex
$-7.6M
FCF MarginFCF / Revenue
-4.0%
Capex IntensityCapex / Revenue
1.6%
Cash ConversionOCF / Net Profit
-0.18×
-0.29×
TTM Free Cash FlowTrailing 4 quarters
$14.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACAD
ACAD
PSIX
PSIX
Q4 25
$-48.7M
$-4.6M
Q3 25
$74.3M
$3.3M
Q2 25
$64.0M
$16.7M
Q1 25
$20.3M
$8.8M
Q4 24
$40.4M
$32.7M
Q3 24
$63.2M
$12.6M
Q2 24
$25.0M
$1.5M
Q1 24
$29.1M
$15.6M
Free Cash Flow
ACAD
ACAD
PSIX
PSIX
Q4 25
$-7.6M
Q3 25
$73.9M
$1.7M
Q2 25
$14.6M
Q1 25
$5.4M
Q4 24
$30.0M
Q3 24
$63.2M
$12.1M
Q2 24
$822.0K
Q1 24
$14.8M
FCF Margin
ACAD
ACAD
PSIX
PSIX
Q4 25
-4.0%
Q3 25
26.5%
0.8%
Q2 25
7.6%
Q1 25
4.0%
Q4 24
20.8%
Q3 24
25.2%
9.7%
Q2 24
0.7%
Q1 24
15.6%
Capex Intensity
ACAD
ACAD
PSIX
PSIX
Q4 25
1.6%
Q3 25
0.1%
0.8%
Q2 25
1.1%
Q1 25
2.5%
Q4 24
1.8%
Q3 24
0.0%
0.3%
Q2 24
0.6%
Q1 24
0.9%
Cash Conversion
ACAD
ACAD
PSIX
PSIX
Q4 25
-0.18×
-0.29×
Q3 25
1.03×
0.12×
Q2 25
2.40×
0.33×
Q1 25
1.07×
0.46×
Q4 24
0.28×
1.40×
Q3 24
1.93×
0.73×
Q2 24
0.75×
0.07×
Q1 24
1.76×
2.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACAD
ACAD

Nuplazid$174.4M61%
Daybue$109.6M39%

PSIX
PSIX

Energy End Market$153.4M80%
Industrial End Market$33.3M17%
Transportation End Market$4.6M2%

Related Comparisons